LBSP Biostats Network

Thursday, May 17, 2018
15.00 - 18.00
Grand Café De Stal
Darwinweg 1, 2333 CR Leiden

The theme for this session will be “Decision making and personalized medicine”. For a drug developer a decision can be to stop or continue development, which dose to select or which patient subgroup to target. For an individual a decision on treatment choice has to be made.

We have two speakers for this session and welcome more on any topic related to decision making and/or personalized medicine.

Speakers will have 20-30 minutes to present followed by roughly 10 minutes of Q&A at the end of their presentation.  Please consider volunteering to present and let the committee know by 2 May latest.
We look forward to hearing from you and to meeting again soon!

Program

  • Welcome
  • SP Biostats NetworkMINDACT trial
    Ewout Steyerberg (LUMC)
    This trial assessed if a gene signature could predict whether or not breast cancer patients would benefit from chemotherapy (in the sense of lowering probability of metastasis).
  • Model informed drug development and quantitative decision making
    Axel Krebs-Brown (Astellas)
  • From data to models, reducing uncertainty in benefit-risk assessment: Application to chronic iron overload in children
    Francesco Bellanti (Certara)
  • Closure and drinks

For Whom

The LBSP Biostatisticians Network is intended for professionals working in biostatistics, including PK/PD and statistical bioinformatics.

Interested to attend? Sign up below!


Want to sign up to receive invitations for this and other events in your inbox? Select your events here.

Sign up for this event




Where to find companies and their profiles? You will find them in our directory.

To the map